Recomienda este artículo a tus amigos:
Indacaterol: The First Once-daily Long-acting Beta2 Agonist for COPD - Milestones in Drug Therapy Alexandre Trifilieff 2014 edition
Indacaterol: The First Once-daily Long-acting Beta2 Agonist for COPD - Milestones in Drug Therapy
Alexandre Trifilieff
Here is a comprehensive overview of the development of Onbrez Breezhaler, a newly approved once-daily inhaled beta2 agonist for treating COPD. Covers design and pre-clinical pharmacology of the molecule, early clinical development, efficacy studies and more.
146 pages, 20 black & white illustrations, 21 colour illustrations, biography
| Medios de comunicación | Libros Hardcover Book (Libro con lomo y cubierta duros) |
| Publicado | 27 de noviembre de 2013 |
| ISBN13 | 9783034807081 |
| Editores | Springer Basel |
| Páginas | 146 |
| Dimensiones | 155 × 235 × 15 mm · 408 g |
| Lengua | Alemán |
| Editor | Trifilieff, Alexandre |